The Defense Logistics Agency plans a national requirements contract for Pantoprazole DR Tablets in 40 MG and 20 MG strengths, with a firm-fixed price structure. The contract includes a one-year base period and four one-year options, and it will be an unrestricted, fully competitive commercial acquisition. Performance will be for Department of Defense customers nationwide through the DLA prime vendor program. The projected solicitation date is May 2026, though DLA may issue it earlier or later. No specific budget amount is provided.